Supplementary Table 1 from Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer

crossref(2023)

引用 0|浏览15
暂无评分
摘要

Interim analysis of Grade {greater than or equal to}3 hematologic toxicity in the first 10 patients recruited to the combination arm (radium-223 + enzalutamide).

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要